AT2R agonist NP-6A4 mitigates aortic stiffness and proteolytic activity in mouse model of aneurysm.

J Cell Mol Med · 2020 · PMC7339180 · PMID 32420690

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

a strong trendP = 0.053so close (0.05 < p ≤ 0.1)

Daugherty's classification of the abdominal aortic lesions showed majority of the lesions with AngII infusion were type III and type IV, whereas with NP‐6A4 treatment showed a strong trend ( P = 0.053) towards type I indicating relatively less severity of aortic lesions (Figure 1B ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.